Breaking News With Anil Singhvi: Boost for Aarti Drugs as import duty slapped on Ciprofloxacin | share price target Rs 848

Breaking News With Anil Singhvi: Zee Business correspondent Chetan Bhutani has said that the Government of India has issued a final notification on one drug which is used to cure many infections. The drug is called Ciprofloxacin Hydrochloride. Now official notification has been imposed on Ciprofloxacin Hydrochloride for 5 years and an official announcement has been made related to this decision. Aarti Drugs share price today is Rs 692, up Rs 21 or 3.2%.

From January 2020, this drug was under investigation as it was coming from China. This decision will benefit Aarti Drugs the most. 

See Zee Business Live TV Streaming Below:

Aarti Drugs is the sole producer of this drug. Siddharth Sedani said that this was a long pending problem for Aarti Drugs. He said if the Anti Dumping restrictions are being imposed then it will benefit Aarti Drugs the most.

Ciprofloxacin Hydrochloride पर 5 साल के लिए ड्यूटी लगी,

कैसे होगा आरती ड्रग्स को इसका फायदा?

जानने के लिए देखें आरती ड्रग्स से जुड़ी #EXCLUSIVE खबर#ZBizExclusive #AartiDrugs @BhutaniChetan @AnilSinghvi_ pic.twitter.com/gM99hKcmFe

— Zee Business (@ZeeBusiness) March 12, 2021

This is a API Segment based company and the fundamentals of the company are extremely strong. Siddharth said they have a target of Rs 848 on Aarti Drugs in 1 year. The stock has consolidated for some time and now it seems ready for an upmove.